Histopathological parameters as predictors for the course of Crohn's disease

Virchows Archiv

Volumn 443, Issue 4, 2003, Pages 501-507

  Bataille, Frauke ^a   Klebl, Frank ^a   Rümmele, Petra ^a   Straub, Rainer H ^a   Wild, Peter ^a   Schölmerich, Jürgen ^a   Hofstädter, Ferdinand ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Crohn's disease; Disease behavior; Histological feature

Indexed keywords

ADULT; ARTICLE; ATROPHY; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE CRYPT; INTESTINE EPITHELIUM; LAMINA PROPRIA; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; CROHN DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0242298236     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0863-6     Document Type: Article

References (22)

1. Borley NR, Mortensen NJ, Kettlewell M, George B, Jewell D, Warren B (2001) Connective tissue changes in ileal Crohn's disease: relationship to disease phenotype and ulcer-associated cell lineage. Dis Colon Rectum 44:388-396
2. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn's Disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8-15
3. Gelbmann CM (2000) Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease - do we have reliable markers? Inflamm Bowel Dis 6:123-131
4. Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, Gay R (1998) Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94:257-265
5. Hilsden RJ, Meddings JB, Hardin J, Gall DG, Sutherland LR (1999) Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis 5:85-91
6. Hirata I, Berrebi G, Austin LL, Keren DF, Dobbins WO (1986) Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 31:593-603
7. Le Berre NL, Heresbach D, Kerbaol M, Caulet S, Bretagne JF, Chaperon J, Gosselin M, Ramée MP (1995) Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol 48:749-753
8. Lennard Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol 170[Suppl]:2-6
9. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845-857
10. McAlindon ME, Gray T, Galvin A, Sewell HF, Podolsky DK, Mahida YR (1998) Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa. Gastroenterology 115:841-848
11. Modigliani R and the GETAID group (1990) Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 98:811-818
12. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenaglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931-968
13. Roseth AG, Aadland E, Jahnsen J, Raknerud N (1997) Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 58:176-180
14. Roseth AG, Fagerhol MK, Aadland E, Schonsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793-798
15. Schreiber S, Nikolaus S, Hampe J, Hamling J, Koop I, Groessner B, Lochs H, Raedler A (1999) Tumor necrosis factor alpha and interleukin 1 beta in relapse of Crohn's disease. Lancet 353:459-461
16. Seldenrijk CA, Morson BC, Meuwissen SG, Schipper NW, Lindeman J, Meijer CJ (1991) Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 32:1514-1520
17. Senju M, Wu KC, Mahida YR, Jewell DP (1990) Two color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's disease. Dig Dis Sci 36:1453-1458
18. Surawicz CM, Belic L (1984) Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 86:104-113
19. Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H (1999) Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 34:55-67
20. Teahon K, Smethurst P, Levi A, Menzies IS, Bjarnason I (1992) Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 33:320-323
21. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15-22
22. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H (1993) Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341:1437-1439